Procaps Group, S.A Total Liabilities and Share Holders Equity 2020-2023 | PROCF
Procaps Group, S.A total liabilities and share holders equity from 2020 to 2023. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
Procaps Group, S.A Annual Total Liabilities and Share Holders Equity (Millions of US $) |
2022 |
$460 |
2021 |
$462 |
2020 |
$360 |
2020 |
$202 |
2019 |
$ |
2019 |
$0 |
2018 |
$0 |
Procaps Group, S.A Quarterly Total Liabilities and Share Holders Equity (Millions of US $) |
2023-09-30 |
$499 |
2023-06-30 |
$491 |
2023-03-31 |
$442 |
2022-12-31 |
$460 |
2022-09-30 |
$471 |
2022-06-30 |
$470 |
2022-03-31 |
$483 |
2021-12-31 |
$462 |
2021-09-30 |
$465 |
2021-06-30 |
$137 |
2021-03-31 |
$202 |
2020-12-31 |
$360 |
2020-09-30 |
$202 |
2020-06-30 |
$203 |
2020-03-31 |
$203 |
2019-12-31 |
$202 |
2019-09-30 |
$0 |
2019-06-30 |
$0 |
2019-03-31 |
$0 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-DRUGS |
$0.125B |
$0.410B |
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
|